Ambrx Biopharma Cayman Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Related People
Fund Service Providers
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Ambrx Biopharma Cayman Inc
CIK #0001836056
EDGAR Form CIK 2011 - 2026
10-K [0001836056]
10-Q [0001836056]
3 [0001836056]
4 [0001836056]
6-K [0001836056]
8-K [0001836056]
SC 13D [0001836056]
SC 13G [0001836056]
Form 13D/13G Filer Form 13D/13G Subject Filed
HOPU Reunion Co Ltd Ambrx Biopharma Inc [2023-10-10]
Paradigm Biocapital Advisors LP Ambrx Biopharma Inc [2023-09-25]
D E Shaw & Co LP Ambrx Biopharma Inc [2023-03-16]
Darwin Global Management Ltd Ambrx Biopharma Inc [2023-03-08]
Commodore Capital LP Ambrx Biopharma Inc [2023-03-03]
Venrock Healthcare Capital Partners III LP Ambrx Biopharma Inc [2023-02-27]
Darwin Global Management Ltd Ambrx Biopharma Inc [2022-12-19]
FMR LLC Ambrx Biopharma Inc [2022-02-09]
WuXi Pharmatech Healthcare Fund I LP Ambrx Biopharma Inc [2022-02-08]
Adage Capital Partners GP LLC Ambrx Biopharma Inc [2022-01-18]
Artal International SCA Ambrx Biopharma Inc [2021-07-12]
Cormorant Asset Management LP Ambrx Biopharma Inc [2021-07-02]
HBM Healthcare Investments Cayman Ltd Ambrx Biopharma Inc [2021-07-02]
Form 3/4/5 Subject 2011 - 2026
Cormorant Global Healthcare Master Fund LP
Chen Bihua
Ambrx Biopharma Cayman Inc
Cormorant Private Healthcare Fund III LP
Cormorant Asset Management LP
Dalesandro Margaret
Aromando Andrew
O'Connor Daniel
Nelson Sonja
Darwin Global Management Limited
View All
Terms | Privacy | Providers | Guide
tony@aum13f.com